HLA-F-AS1 Gene

Name HLA-F antisense RNA 1
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Long non‐coding RNA HLA-F-AS1 has emerged as an important regulator in several human diseases, particularly in cancer, where its function appears to be highly context-dependent. In colorectal cancer, HLA-F-AS1 is upregulated and acts as a competing endogenous RNA that sponges microRNAs (miR-330-3p and miR-375) to derepress targets such as profilin 1 (PFN1). This interaction enhances cell proliferation, migration, invasion, and epithelial–mesenchymal transition, and even modulates the tumor microenvironment through altered macrophage polarization via extracellular vesicles."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In glioblastoma, HLA-F-AS1 is highly expressed where it promotes cell migration and invasion, and suppresses apoptosis by sponging the tumor suppressor lncRNA MEG3."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In triple-negative breast cancer and cutaneous squamous cell carcinoma, HLA-F-AS1 contributes to tumor progression by sequestering miRNAs—such as miR-541-3p in TNBC and miR-17-5p/miR-20b-5p in cSCC—leading to the upregulation of downstream targets including TRABD, CCND1, and E2F1. These actions facilitate cell cycle progression, increase proliferative capacity, and maintain cancer stemness."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In a contrasting role, ovarian cancer tissues exhibit downregulated HLA-F-AS1 expression. Restoration of HLA-F-AS1 in ovarian cancer cells attenuates tumor growth by sponging miR-21-3p, which in turn upregulates the tumor suppressor PEG3, thereby inhibiting proliferation and migration."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Additional studies in lung adenocarcinoma have identified HLA-F-AS1 among several dysregulated lncRNAs, suggesting its potential as a diagnostic indicator."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Furthermore, assessment of immune-related gene panels in non-small cell lung cancer has revealed that HLA-F-AS1 expression may serve as a predictive biomarker for response to anti-PD-1 therapy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond oncogenesis, genetic association studies have implicated variants within or near the HLA-F-AS1 locus in neuropsychiatric and inflammatory conditions, including schizophrenia, bipolar disorder, and Behçet’s disease, underscoring its broader regulatory significance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, HLA-F-AS1 plays multifaceted roles in disease progression by modulating gene expression through a miRNA sponging mechanism. Its oncogenic or tumor-suppressive effects are highly dependent on the cellular context and tumor type, while its genetic variants may contribute to disease susceptibility beyond cancer.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yongguo Huang, Hong Sun, Xiang Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HLA-F-AS1/miR-330-3p/PFN1 axis promotes colorectal cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Life Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lfs.2019.117180"}], "href": "https://doi.org/10.1016/j.lfs.2019.117180"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31863778"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31863778"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jing Zhang, Shiquan Li, Xiaona Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HLA-F-AS1 promotes colorectal cancer metastasis by inducing PFN1 in colorectal cancer-derived extracellular vesicles and mediating macrophage polarization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Gene Ther (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41417-020-00276-3"}], "href": "https://doi.org/10.1038/s41417-020-00276-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33531647"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33531647"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yanhua Wang, Teng Xie, Huaming Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HLA-F-AS1 Enhances the Migration, Invasion and Apoptosis of Glioblastoma Cells by Targeting lncRNA MEG3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Manag Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/CMAR.S322351"}], "href": "https://doi.org/10.2147/CMAR.S322351"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34934358"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34934358"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Di Wu, Hongyao Jia, Zhiru Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioorg Chem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bioorg.2021.104722"}], "href": "https://doi.org/10.1016/j.bioorg.2021.104722"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33618253"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33618253"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yaqin Xu, Yingying Dong, Yunhua Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identifying an lncRNA-Related ceRNA Network to Reveal Novel Targets for a Cutaneous Squamous Cell Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biology (Basel) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/biology10050432"}], "href": "https://doi.org/10.3390/biology10050432"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34068010"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34068010"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Wenhong Fang, Yufang Xia "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HLA-F-AS1 attenuates the ovarian cancer development by targeting miR-21-3p/PEG3 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Anticancer Drugs (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/CAD.0000000000001288"}], "href": "https://doi.org/10.1097/CAD.0000000000001288"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35276697"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35276697"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Zhiyi Yang, Hongli Li, Zhaoyan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Microarray expression profile of long non-coding RNAs in human lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thorac Cancer (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/1759-7714.12845"}], "href": "https://doi.org/10.1111/1759-7714.12845"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30151992"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30151992"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Bolin Chen, Min Yang, Kang Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immune-related genes and gene sets for predicting the response to anti-programmed death 1 therapy in patients with primary or metastatic non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Lett (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ol.2021.12801"}], "href": "https://doi.org/10.3892/ol.2021.12801"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34084219"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34084219"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Takeo Saito, Kenji Kondo, Yoshimi Iwayama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Replication and cross-phenotype study based upon schizophrenia GWASs data in the Japanese population: support for association of MHC region with psychosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet B Neuropsychiatr Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.b.32246"}], "href": "https://doi.org/10.1002/ajmg.b.32246"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24888570"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24888570"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Travis Hughes, Patrick Coit, Adam Adler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.2551"}], "href": "https://doi.org/10.1038/ng.2551"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23396137"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23396137"}]}]}]}
NCBI Gene ID 285830
API
Download Associations
Predicted Functions View HLA-F-AS1's ARCHS4 Predicted Functions.
Co-expressed Genes View HLA-F-AS1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View HLA-F-AS1's ARCHS4 Predicted Functions.

Functional Associations

HLA-F-AS1 has 1,581 functional associations with biological entities spanning 5 categories (organism, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 23 datasets.

Click the + buttons to view associations for HLA-F-AS1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of HLA-F-AS1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of HLA-F-AS1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of HLA-F-AS1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of HLA-F-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of HLA-F-AS1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of HLA-F-AS1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of HLA-F-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of HLA-F-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of HLA-F-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of HLA-F-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of HLA-F-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of HLA-F-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of HLA-F-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of HLA-F-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of HLA-F-AS1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWASdb SNP-Disease Associations diseases associated with HLA-F-AS1 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with HLA-F-AS1 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with HLA-F-AS1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of HLA-F-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of HLA-F-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of HLA-F-AS1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of HLA-F-AS1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of HLA-F-AS1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.